Afyx Development A/S: Financial statements 2022
CVR: 35839739
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Afyx Development A/S (CVR 35839739) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -8,601,049 and a net result of DKK -24,274,950 compared with DKK -35,049,956 the year before. Equity in the 2022 report amounted to DKK -112,308,790. The company had 3 employees in the financial year.
- Gross Profit
- DKK -8,601,049
- Profit/Loss
- DKK -24,274,950
- Equity
- DKK -112,308,790
- Total Assets
- DKK 16,263,761
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -8.6 mio. | -24.3 mio. | -112.3 mio. | 3 |
| 2021 | - | -27.4 mio. | -35 mio. | -88 mio. | 6 |
| 2020 | - | -36.2 mio. | -49.5 mio. | -53 mio. | 10 |
| 2019 | - | -52.5 mio. | -57.7 mio. | -3.5 mio. | 10 |
| 2018 | - | -37.6 mio. | -45.1 mio. | 54.2 mio. | 8 |
Official annual report
Keep an eye on Afyx Development A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Afyx Development A/S has published its annual report for 2021. Gross profit came to DKK -27,442,244, and the net result was DKK -35,049,956.
As of February 22, 2022, Nishan de Silva has left the board of directors of Afyx Development A/S.
As of February 22, 2022, Lars Siim Madsen is registered as adm. dir. of Afyx Development A/S.
As of February 22, 2022, Nishan de Silva has stepped down as adm. dir. of Afyx Development A/S.
About Afyx Development A/S
Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Therapeutics A/S. The company has 8 employees (2018). In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity in the 2025 report amounted to DKK -7,253,987.